U.S., March 25 -- ClinicalTrials.gov registry received information related to the study (NCT06890455) titled 'Fecal Calprotectin in Patients Infected with Intestinal Protozoan Infections' on March 17.
Brief Summary: Calprotectin extracted from stool can be detected easily using ELISA. Numerous studies have shown that fecal calprotectin concentrations demonstrate a good correlation with intestinal inflammation This study aims to detect the relationship between fecal calprotectin and Blastocystis hominis and Entamoeba histolytica infections.
Study Start Date: March, 2025
Study Type: OBSERVATIONAL
Condition:
Fecal Calprotectin in Intestinal Protozoa
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Sohag University
Information provided b...